Study finds higher Ischemic events and mortality in transcatheter valve replacement patients taking non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists.
Low-risk atrial fibrillation patients who take oral anticoagulants have a lower risk of dementia than those who do not, a study says.
The use of direct‐acting oral anticoagulants has increased among nursing home residents with atrial fibrillation.
Overestimating the bleeding risk of anticoagulants may lead to poor compliance.
Bleeding in patients with nonvalvular atrial fibrillation and coronary syndrome was reduced by apixaban versus vitamin K antagonists.
Many kidney disease patients with atrial fibrillation are not treated with anticoagulation, increasing their risk of stroke.
Study finds different anticoagulation treatment levels for patients with cognitive problems.
A meta-analysis of 95 studies indicates lower risk of stroke and intracranial hemorrhage.
DOACs are as good as warfarin in preventing atrial fibrillation complications.
Three cardiology groups now recommend using NOACs over warfarin in atrial fibrillation.